Datos

Rajita Sinha

Department of Psychiatry

Yale University School of Medicine

VULNERABILITY AS CAUSE OF SUBSTANCE ABUSE: STRESS

Harvey Skinner

Department of Public Health Sciences

University of Toronto, Ontario, Canada ASSESSMENT OF SUBSTANCE ABUSE: DAST

John Slade

University of Medicine and Dentistry of New Jersey, New Brunswick, NJ TOBACCO: INDUSTRY

Reginald G. Smart

Addiction Research Foundation, Toronto, Canada CANADA, DRUG AND ALCOHOL USE IN

David E. Smith

Haight-Ashbury Free Clinics Inc., San Francisco, CA COMPLICATIONS: DERMATOLOGICAL COMPLICATIONS: ROUTE OF ADMINISTRATION ETHNIC ISSUES AND CULTURAL RELEVANCE IN

TREATMENT TREATMENT PROGRAMS/CENTERS/ORGANIZATIONS: AN HISTORICAL PERSPECTIVE

James E. Smith

Department of Physiology and Pharmacology

Bowman Gray Medical School

Wake Forest University, Winston-Salem, NC BRAIN STRUCTURES AND DRUGS LIMBIC SYSTEM NUCLEUS ACCUMBENS

Robin Solit

Department of Psychology

University of California, San Diego, CA TREATMENT

PROGRAMS/CENTERS/ORGANIZATIONS: AN HISTORICAL PERSPECTIVE

Bob Sokol

Wayne State University School of Medicine

Detroit, MI

ASSESSMENT OF SUBSTANCE ABUSE: T-ACE

David Spiegel

Department of Psychiatry and Behavioral Science

Stanford University School of Medicine, Stanford, CA TREATMENT TYPES: HYPNOSIS

John Stang

National Addiction Centre, London, England BRITISH SYSTEM OF DRUG-ADDICTION TREATMENT

June M. Stapleton

Addiction Research Center

National Institute on Drug Abuse, Baltimore, MD IMAGING, TECHNIQUES: VISUALIZING THE LIVING BRAIN

Marvin Steinberg

Connecticut Council on Problem Gambling, Guilford, CT

GAMBLING ADDICTION: ASSESSMENT GAMBLING ADDICTION: EPIDEMIOLOGY

Mark S. Steinitz

Department of State

Bureau of Intelligence and Research Washington, DC TERRORISM AND DRUGS

Robert S. Stephens

Department of Psychology

Virginia Polytechnic Institute, Blacksburg, VA

Verner Stillner

Department of Psychiatry University of Kentucky, Lexington, KY DOVER'S POWER

Amy L. Stirling

Department of Psychology Wayne State University, Detroit, MI PROFESSIONAL CREDENTIALING

Maxine Stitzer

Behavioral Pharmacology Research Unit Francis Scott Key Medical Center, Baltimore, MD REINFORCEMENT

TREATMENT: HEROIN, BEHAVIORAL APPROACHES

Tim Stockwell

National Centre for Research into the Prevention of

Drug Abuse Curtin University, Perth, Australia TREATMENT TYPES: NONMEDICAL DETOXIFICATION

Carla L. Storr

Center for Substance Abuse Research The University of Maryland, College Park, MD ADOLESCENTS AND DRUG USE EPIDEMICS OF DRUG ABUSE

Amy Loerch Strumolo

Farmington Hills, MI

CAUSES OF SUBSTANCE ABUSE: GENETIC FACTORS

DIAGNOSTIC AND STATISTICAL MANUAL (DSM) HAIR ANALYSIS AS A TEST FOR DRUG USE

John T. Sullivan

Center for Chemical Dependence Francis Scott Key Medical Center, Baltimore, MD DETOXIFICATION: AS ASPECT OF TREATMENT COMPLICATIONS: MEDICAL AND BEHAVIORAL

TOXICITY OVERVIEW WITHDRAWAL: ALCOHOL

Nancy L. Sutherland

Alcohol and Drug Abuse Institute University of Washington, Seattle, WA

ALCOHOL: PSYCHOLOGICAL CONSEQUENCES OF CHRONIC ABUSE

Dace Svikis

National Institute on Drug Abuse, Rockville, MD VULNERABILITY AS CAUSE OF SUBSTANCE

ABUSE: AN OVERVIEW VULNERABILITY AS CAUSE OF SUBSTANCE ABUSE: GENETICS

Neil Swan

ROW Sciences, Rockville, MD

INHALANTS: EXTENT OF USE AND COMPLICATIONS

Robert M. Swift

Department of Psychiatry Roger Williams Hospital, Providence, RI TREATMENT: POLYDRUG ABUSE, PHARMACOTHERAPY

John D. Swisher

Pennsylvania State University, State College, PA EDUCATION AND PREVENTION

Ralph E. Tarter

Western Psychiatric Institute University of Pittsburgh School of Medicine Pittsburgh, PA

ATTENTION DEFICIT DISORDER CONDUCT DISORDER AND DRUG USE COPING AND DRUG USE

Beti Thompson

Fred Hutchinson Cancer Research Center, Seattle, WA TOBACCO: SMOKING CESSATION AND WEIGHT GAIN

WITHDRAWAL: NICOTINE (TOBACCO)

W. Kenneth Thompson

Bureau of International Narcotics Matters Chevy Chase, MD

FOREIGN POLICY AND DRUGS

Stephen T. Tiffany

Department of Psychological Sciences Purdue University, West Lafayette, IN CRAVING

Gillian Tober

Leeds Addiction Unit, Leeds, England

UKAT: U.K. ALCOHOL TREATMENT TRIAL

Michael Tonry

University of Minnesota Law School Minneapolis, MN MANDATORY SENTENCING ROCKEFELLER DRUG LAW

Harrison M. Trice

New York School of Industry and Labor Relations Cornell University, Ithaca, NY AL-ANON

ALATEEN

ALCOHOLICS ANONYMOUS (AA) COCAINE ANONYMOUS (CA) NARCOTICS ANONYMOUS (NA) TREATMENT TYPES: SELF-HELP AND

ANONYMOUS GROUPS TREATMENT TYPES: TWELVE STEPS, THE

Alison M. Trinkoff

School of Nursing

University of Maryland, Baltimore, MD ADOLESCENTS AND DRUG USE

George R. Uhl

Molecular Neurobiology Laboratory, Addiction Research Center

National Institute on Drug Abuse, Baltimore, MD ANTIDEPRESSANT ANTIPSYCHOTIC NEUROLEPTIC RECEPTOR: NMDA

SUBSTANCE ABUSE, GENETIC FACTORS AND VULNERABILITY

James Van Wert

Small Business Administration, Silver Springs, MD COLOMBIA AS DRUG SOURCE CROP-CONTROL POLICIES (DRUGS) GOLDEN TRIANGLE AS DRUG SOURCE INTERNATIONAL DRUG SUPPLY SYSTEMS MEXICO AS DRUG SOURCE SOURCE COUNTRIES FOR ILLICIT DRUGS TRANSIT COUNTRIES FOR ILLICIT DRUGS

Jane Velez

Project Return Foundation, Inc., New York, NY TREATMENT PROGRAMS/CENTERS/ ORGANIZATIONS: AN HISTORICAL PERSPECTIVE

Robert E. Vestal

Clinical Pharmacology and Gerontology Research Unit

Veterans Administration Medical Center Boise, ID AGING. DRUGS, AND ALCOHOL

David Vlahov

School of Hygiene and Mental Health

Johns Hopkins University, Baltimore, MD ARGOT

Alexander C. Wagenaar

School of Public Health, Division of Epidemiology

University of Minnesota, Minneapolis, MN ALCOHOL: MINIUM DRINKING AGE LAWS

Elizabeth Wallace

Substance Abuse Treatment Unit Yale University School of Medicine New Haven, CT TREATMENT TYPES: PHARMACOTHERAPY, AN OVERVIEW

John M. Wallace, Jr.

Institute for Social Research University of Michigan, Ann Arbor, MI RELIGION AND DRUG USE

Michael Walsh

Drug Advisory Council

Executive Office of the President, Washington, DC INDUSTRY AND WORKPLACE, DRUG USE IN

Sharon L. Walsh

Francis Scott Key Medical Center, Baltimore, MD RESEARCH: MEASURING EFFECTS OF DRUGS ON MOOD

Ronald R. Watson

College of Public Health and School of Medicine University of Arizona, Tucson, AZ ALCOHOL AND AIDS ALCOHOL: COMPLICATIONS COCAETHYLENE COMPLICATIONS: IMMUNOLOGIC PARASITE DISEASES AND ALCOHOL TREATMENT PROGRAMS/CENTERS/ORGANIZATIONS: AN HISTORICAL PERSPECTIVE

Andrew T. Weil

Tucson, AZ

POLICY ALTERNATIVES: SAFE USE OF DRUGS

Meryle Weinstein

Psychiatry Service

Veterans Affairs Medical Center San Francisco, CA TREATMENT TYPES: PSYCHOLOGICAL APPROACHES

Roger Weiss

Department of Psychiatry McLean Hospital, Belmont, MA FREEBASING

Donald R. Wesson

Beverly Hills, CA

IMPAIRED PHYSICIANS AND MEDICAL WORKERS

Harry R. Wexler

The Psychology Center, Laguna Beach, CA CALIFORNIA CIVIL COMMITMENT PROGRAM CIVIL COMMITMENT

NEW YORK STATE CIVIL COMMITMENT PROGRAM PRISONS AND JAILS

PRISONS AND JAILS: DRUG TREATMENT IN PRISONS AND JAILS: DRUG USE AND AIDS IN RATIONAL AUTHORITY

Richard L. Williams

Alexandria, VA

BORDER MANAGEMENT

U.S. GOVERNMENT: DRUG POLICY OFFICES IN

THE EXECUTIVE OFFICE OF THE PRESIDENT U.S. GOVERNMENT THE ORGANIZATION OF U.S.

DRUG POLICY U.S. GOVERNMENT AGENCIES: BUREAU OF

NARCOTICS AND DANGEROUS DRUGS (BNDD) U.S. GOVERNMENT AGENCIES: OFFICE OF DRUG

ABUSE LAW ENFORCEMENT (ODALE) U.S. GOVERNMENT AGENCIES: OFFICE OF DRUG

ABUSE POLICY (ODAP) U.S. GOVERNMENT AGENCIES: OFFICE OF

NATIONAL DRUG CONTROL POLICY (ONDCP) U.S. GOVERNMENT AGENCIES: U.S. CUSTOMS SERVICE

Amy Windham

Department of Mental Hygiene

Johns Hopkins School of Hygiene and Mental Health Baltimore, MD ZERO TOLERANCE

George Winokur

Department of Psychiatry

University of Iowa College of Medicine, Iowa City, IA COMPLICATIONS: MENTAL DISORDERS

Eric D. Wish

Center for Substance Abuse Research

University of Maryland, College Park, MD DRUG USE FORECASTING PROGRAM (DUF)

Friedner D. Wittman

KLEW Associates, Berkeley, CA

ALCOHOL- AND DRUG-FREE HOUSING

Ronald W. Wood

New York University Medical Center Tuxedo Park, NY INHALANTS

George Woody

University of Pennsylvania, Philadelphia, PA BEHAVIORAL ECONOMICS

William Woolverton

Department of Pharmacological Sciences Prizker School of Medicine, Chicago, IL ABUSE LIABILITY OF DRUGS: TESTING IN ANIMALS

RESEARCH, ANIMAL MODEL: AN OVERVIEW OF

DRUG ABUSE RESEARCH, ANIMAL MODEL: CONDITIONED

PLACE PREFERENCE RESEARCH, ANIMAL MODEL: DRUG

DISCRIMINATION STUDIES RESEARCH, ANIMAL MODEL: DRUG SELF-ADMINISTRATION

Colleen J. Yoo

Department of Health Policy and Management Johns Hopkins School of Public Health, Baltimore, MD

VULNERABILITY AS CAUSE OF SUBSTANCE ABUSE: SEXUAL AND PHYSICAL ABUSE

Robert Zaczek

Du Pont Merck Pharmaceuticals Wilmington, DE FLY AGARIC JIMSONWEED KAVA

SCOPOLAMINE AND ATROPINE

Marvin Zuckerman

Department of Psychology University of Delaware, Newark, DE

VULNERABILITY AS CAUSE OF SUBSTANCE ABUSE: SENSATION SEEKING

Joan Ellen Zweben

School of Medicine

University of California at San Francisco San

Francisco, CA Clinic and Medical Group and East Bay Community Recovery Project, Oakland, CA METHADONE MAINTENANCE PROGRAMS

Home Detox

Home Detox

Never before revealed. Home Detox - Step By Step Guide To Dextoxify The Body. Has too much late night behavior and partying got you feeling bad about yourself? Are you trying to lose weight but nothing is happening? Maybe you are just sick of all of the toxins that are in the air you breathe, the water you drink and the foods you eat. If so, then you need to do something about it. If you find yourself feeling bad about your health, there are ways that you can help your body right at home.

Get My Free Ebook


Post a comment